Publications by authors named "Anna Casartelli"
Article Synopsis
- Patients with severe asthma often suffer from chronic rhinosinusitis (CRS), which can worsen symptoms and complicate treatment; this study examines the effects of biologic treatments on quality of life for these patients.
- The research involved analyzing patient data before and after treatment with biologics (omalizumab, mepolizumab, benralizumab, dupilumab) over 12 months, measuring improvements in quality of life indicators.
- Results showed significant improvements in CRS-related quality of life and asthma control after 3, 6, and 12 months of treatment, particularly with dupilumab, emphasizing the benefit of targeting type 2 inflammation in these patients.
